Introduction
Osteoarthritis (OA) is a disease that causes pain and disability. It is usually slowly progressive, and cartilage degeneration with a loss of joint space (a common measure of progression) is often not continuous, as evidenced by numerous clinical trials and longitudinal studies. The emphasis of research and clinical trials has been on the degeneration of articular cartilage, being required with synovial fluid for the almost frictionless articulation and a key determinant, with the meniscus, of knee joint space on radiographic analysis. However, emerging evidence exists that all or almost all joint tissues are involved and/or affected by this degenerative process (Fig. 1) .
OA Joint Pathology
Cartilage degeneration (see the article by Mary Goldring in this Symposium) involves a change in the chondrocyte phenotype called chondrocyte hypertrophy [14, 15] , which in pathological situations can be induced by altered mechanical loading of chondrocytes [19] . This is normally seen in endochondral ossification in growth plates, fracture callous, and osteophyte formation, the latter being a feature of OA joint pathology. This hypertrophic state is characterized by abnormal cell behavior with increased resorption of collagen and proteoglycan in extracellular matrix, culminating in cell death [14, 15] . This change is associated in OA cartilage with onset of canonical Wnt signaling that is normally involved in cartilage and bone development [1, 12, 21] . Based on analytical information, such signaling changes may also partly explain the accompanying synovitis [1] . In view of the fact that the canonical Wnt signaling pathway is essential for normal osteoblast and chondrocyte maturation and SNPs of genes involved in this pathway exhibit associations with both OA and osteoporosis [12] , abnormalities in this signaling pathway that are changed in cartilage, synovium, and bone in OA may help explain the pathology seen not only in articular cartilage but also in the synovium and in subchondral bone.
In OA, subchondral bone is characterized by changes that include bone "bruises" and cyst formation (seen with MRI [10, 11] ) and increased bone turnover (seen by scintigraphy [3, 13] ). These are all indicative of abnormal bone remodeling. They are also observed in conjunction with meniscal derangement [11] . These subchondral bone changes may result from a common denominator such as the canonical Wnt pathway or some other common pathway, the activation and/or regulation of which is changed in OA. Thus, it is important to think more of common denominators when considering pathology in different joint tissues, rather than considering each tissue alone as having independent and distinct pathology without a common cause. Changes in subchondral bone are thought by many to precede degenerative changes in articular cartilage. However, recent studies using MRI have come to the opposite conclusion [10] . Changes in menisci (see the article by David Hunter in this Symposium), seen with MRI, are common in older persons [5] and may precede those in articular cartilage as well as being closely associated with early subchondral bone changes [11] and synovial effusions [16] in OA.
Ligaments have received little attention in OA. However, histological examinations of macroscopically intact anterior cruciate ligaments at knee arthroplasty [4] and MRI analyses of collateral finger ligaments of patients with hand OA [17, 18] revealed common degenerative changes. The insertion sites into bone (entheses) of collateral ligaments also showed evidence of pathology as well as in the adjacent bone [17] .
Synovitis, often of an innate immune variety probably caused by joint debris and calcium phosphate crystals that accumulate in OA in synovial fluid [18] , is a well defined feature of knee OA (see the article by Carla Scanzello in this Symposium), being more pronounced in about 10% of the population. A mild synovitis is seen in a majority of patients. This may hasten joint damage through generation of proinflammatory cytokines and account, in part, for joint pain. Joint effusions normally associated with pronounced synovitis are also associated with meniscal damage [16] .
Joint pain, which is the biggest problem for most patients with OA (see the article by Bruce Kidd in this Symposium) may also result from changes in nociception within subchondral bone and entheses as a consequence of altered loading within the joint. It is also associated with structural changes and synovitis [7] . The structural alterations may also involve articular cartilage. Although they are aneural, articular cartilage may cause indirect stimulation of sensory neurons and neuropathic pain based on evidence from recent biomarker analyses [8] .
The infrapatellar fat pad of the knee is frequently a site of inflammation in OA with upregulation of chemokine expression [2, 9] . Whether this also contributes to knee pain and overall pathology is unclear.
Synovial fluid analyses provide an overall picture of joint degeneration in OA [6] . Marked increases occur in extracellular matrix components of cartilage and bone as well as of hyaluronan, (reflective of synovitis), proteinases, prostaglandins, cytokines and growth factors [8, 14, 15] . The presence of crystals of calcium phosphate is often associated with increased matrix calcification [20] as seen in chondrocyte hypertrophy. Proteonomic analyses of the multiple components are providing new insights into joint disease [6] .
Summary
So, there can be little doubt that the whole joint is involved in OA, resulting in changes in function and proprioception and onset of altered nociception and pain that compound the problem. So, functional assessments of joint function should also be included in any measures of joint changes in OA. Many additional parameters might help in detecting and measuring disease onset and progression instead of relying on traditional measures of loss of and/or damage to articular cartilage. Most, if not all, joint tissues potentially offer important new opportunities as targets for therapeutic intervention. Disclosures The author certifies that he or she has no commercial associations (e.g., consultancies, stock ownership, equity interest, patent/licensing arrangements, etc.) that might pose a conflict of interest in connection with the submitted article.
